Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery

Thrombosis Research

Volumn 104, Issue 5, 2001, Pages 309-315

  Modrau, Ivy I S ^a   Iversen, Lene L H ^a   Thorlacius Ussing, Ole O ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood coagulation; Colorectal neoplasm; Fibrinolysis; Plasminogen activator inhibitor type 1; Soluble fibrin; Surgery; Thrombin antithrombin III complex; Total fibrinogen and fibrin degradation products; Urokinase type plasminogen activator; Urokinase type plasminogen activator receptor

Indexed keywords

FIBRIN; FIBRINOGEN DEGRADATION PRODUCT; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX; UROKINASE; UROKINASE RECEPTOR;

ABDOMINAL SURGERY; ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; COLORECTAL DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035587095     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00373-5     Document Type: Article

References (15)

1. Thromboembolic problems in colorectal cancer surgery
2. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment
3. Hemostatic alterations in cancer patients
4. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease - A preliminary study
5. Laboratory diagnosis of the thrombophilic state in cancer patients
6. Haemostatic activation before and after surgery in patients with and without gastric malignancy
7. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers
8. Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer
9. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery
10. Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas
11. Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer
12. Association between plasma plasminogen activator inhibitor-1 and survival in colorectal cancer
13. Clinical value of determination of urokinase-type activator antigen in plasma for detection of colorectal cancer: Comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen
14. The influence of different procedures of general anaesthesia on platelet function, coagulation and the fibrinolytic system
15. The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review